Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
US5767068A · kind A · utility
32Cited by
1References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 1997 |
| Grant date | Jun 16, 1998 |
| Priority date | — |
| Expiry date | Feb 13, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-Pseudomonas aeruginosa agent which is substantially pure biologically active colistin, its component, a mixture thereof or a pharmaceutically acceptable salt thereof delivered as an aerosol or dry powder formulation. A formulation and method for preparation of substantially pure biologically active colistin, its components, mixtures thereof and a pharmaceutically acceptable salts thereof. A method for treatment and prophylaxis of Pseudomonas aeruginosa, Stenotrophomonas maltophilia or other susceptible pulmonary bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.